Skip to main content
Top
Published in: Intensive Care Medicine 4/2009

01-04-2009 | Brief Report

Submission of clinical studies to ethics committees or clinical trials registers: the authors’ point of view

Authors: Daniel Pehboeck, Matthias Hohlrieder, Volker Wenzel, Arnulf Benzer

Published in: Intensive Care Medicine | Issue 4/2009

Login to get access

Abstract

To evaluate the satisfaction of clinical scientists when submitting study drafts to an ethics committee/clinical trials register (CLINICALTRIALS, EUDRACT, ISRCTN) we conducted an online survey of 240 authors publishing in anesthesia/critical care medicine (A) or in major general medical (M) journals from January to December 2007. No statistical difference between groups A and M was seen with regard to the number of studies submitted to ethics committees or registered in various clinical trials registers. On a visual analogue scale (VAS −10 to +10), the subjective evaluation of the effort required to submit a study draft to an ethics committee or enter it in a clinical trials register produced almost only negative grades in both groups. The mean different perceptions ranged from −3.5 to −0.1 in group A and from −4.4 to −0.2 (except for +0.1 and 1.9 in 2 subgroups) in group M. The authors in both groups gave a positive score to the better transparency in scientific research resulting from introduction of the clinical trials registers (+2.4 in group A, +4.8 in group M). The results of our study indicate widespread author dissatisfaction when submitting a clinical trial to ethics committees or clinical trials registers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hopewell S, Clarke M, Stewart L, Tierney J (2007) Time to publication for results of clinical trials. Cochrane Database Syst Rev 18:MR000011 Hopewell S, Clarke M, Stewart L, Tierney J (2007) Time to publication for results of clinical trials. Cochrane Database Syst Rev 18:MR000011
2.
go back to reference European Parliament. Directive 2001/20/EC on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities, Brussels, 1 May 2001 European Parliament. Directive 2001/20/EC on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities, Brussels, 1 May 2001
3.
4.
go back to reference Yusuf S (2004) Randomized clinical trials: slow death by a thousand unnecessary policies? Can Med Assoc J 171:889–892CrossRef Yusuf S (2004) Randomized clinical trials: slow death by a thousand unnecessary policies? Can Med Assoc J 171:889–892CrossRef
5.
go back to reference De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB, International Committee of Medical Journal Editors (2004) Clinical trial registration. A statement from the International Committee of Medical Journal Editors. Ann Intern Med 141:477–478PubMed De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB, International Committee of Medical Journal Editors (2004) Clinical trial registration. A statement from the International Committee of Medical Journal Editors. Ann Intern Med 141:477–478PubMed
6.
go back to reference Schwarz S, Frölich L, Striebel JP, Hennerici MG (2007) The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials? Dtsch Med Wochenschr 132:108–112PubMedCrossRef Schwarz S, Frölich L, Striebel JP, Hennerici MG (2007) The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials? Dtsch Med Wochenschr 132:108–112PubMedCrossRef
7.
8.
go back to reference Lambers Heerspink HJ, Dobre D, Hillege HL, Grobbee DE, de Zeeuw D (2008) Does the European Clinical Trials Directive really improve clinical trial approval time? Br J Clin Pharmacol 66:546–550PubMedCrossRef Lambers Heerspink HJ, Dobre D, Hillege HL, Grobbee DE, de Zeeuw D (2008) Does the European Clinical Trials Directive really improve clinical trial approval time? Br J Clin Pharmacol 66:546–550PubMedCrossRef
Metadata
Title
Submission of clinical studies to ethics committees or clinical trials registers: the authors’ point of view
Authors
Daniel Pehboeck
Matthias Hohlrieder
Volker Wenzel
Arnulf Benzer
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 4/2009
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-009-1434-3

Other articles of this Issue 4/2009

Intensive Care Medicine 4/2009 Go to the issue